Guaiacolsulfonate or sulfoguaiacolum
- Level
- Commodity
- Parent
- 51162600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162636This classification denotes an antitussive agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 713AJ00NPG. European Medicines Agency schedules Sulfogaiacol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10740MIG. Sulfogaiacol generally arises in the molecular formula C7H8O5S.K. The term SULFOGAIACOL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 16, no. 3 1962, list 4.) SULFOGAIACOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: C1=CC=C(C(=C1)OCO)S(=O)(=O)[O-].[K+].
Same parent
Under 51162600 · 55Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.